MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 121 to 140 of 30,876 approvalsPage 7 of 1544

Actimax

Issued: May 31, 2024

HYPRO

Issued: May 31, 2024

Kiddymox

Issued: May 31, 2024

Fungby

Issued: May 31, 2024

Diura

Issued: May 31, 2024

Vercemol

Issued: May 31, 2024

Unbranded

Issued: May 31, 2024

None

Issued: May 31, 2023

Resistan-Cee

Issued: May 31, 2023

None

Issued: May 31, 2023

BEZOLIN

Issued: May 31, 2023

Selegos

Issued: May 31, 2023

Corstaph

Issued: May 31, 2023

Mupicare

Issued: May 31, 2023

Triforam

Issued: May 31, 2023

Quetafarm

Issued: May 31, 2023

Rostad

Issued: May 31, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.